Research-grade peptides sold australia wide with discreet shipping
Rigurous design
All Peptides tested with COA companies above 99.5% Purity
Disclaimer
Peptide's well sell are for Research Purposes Only,
Durable & free shipping
ORDERS DELIVERED WITHIN 7-12 BUSINESS DAYS, PACKAGES HANDLED AND PACKED WITH DURABLE MATERIAL
TIRZEPATIDE VS RETATRUTIDE IN CLINICAL STUDIES
Tirzepatide is a dual GLP‑1/GIP agonist, while Retatrutide is a triple agonist that binds GLP‑1, GIP and glucagon receptors at the same time.
Retatrutide has a longer peptide chain (39 amino acids) with rare non‑natural amino acids and complicated fatty acid modification steps. It needs far more chemical cycles and 17 rounds of HPLC purification, compared to only 9 steps for dual‑target peptides like Tirzepatide. Raw material cost for Retatrutide API is over 130% higher than Tirzepatide’s base material cost.